Confidence Level
Return
Days hold
Return on $1k investment
On Mar 3, Verve Therapeutics (VERV) was assigned a Buy signal. This signal was predicated on several factors, including an encouraging high , a month over month spike in employee satisfaction, and a month over month spike in business outlook across the company's employees.
The position was exited on Apr 4, due to a triggered stop loss. By the exit, the price was down by -41.3%.